Myelodysplastic syndromes: biology and treatment.
Jädersten, M
Myelodysplastic syndromes: biology and treatment. [electronic resource] - Journal of internal medicine Mar 2009 - 307-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1365-2796
10.1111/j.1365-2796.2008.02052.x doi
Antineoplastic Agents--therapeutic use
Blood Transfusion
Chromosomes, Human, Pair 5--genetics
Disease Progression
Erythropoietin--therapeutic use
Female
Humans
Immunosuppressive Agents--therapeutic use
Iron Chelating Agents--therapeutic use
Lenalidomide
Male
Myelodysplastic Syndromes--classification
Recombinant Proteins
Sequence Deletion
Thalidomide--analogs & derivatives
World Health Organization
Myelodysplastic syndromes: biology and treatment. [electronic resource] - Journal of internal medicine Mar 2009 - 307-28 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1365-2796
10.1111/j.1365-2796.2008.02052.x doi
Antineoplastic Agents--therapeutic use
Blood Transfusion
Chromosomes, Human, Pair 5--genetics
Disease Progression
Erythropoietin--therapeutic use
Female
Humans
Immunosuppressive Agents--therapeutic use
Iron Chelating Agents--therapeutic use
Lenalidomide
Male
Myelodysplastic Syndromes--classification
Recombinant Proteins
Sequence Deletion
Thalidomide--analogs & derivatives
World Health Organization